We provide you with 20 years of free, institutional-grade data for ME stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ME. Explore the full financial landscape of ME stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|
The information provided in this report about ME stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
23andMe(NASDAQ:ME) 
23andMe, Inc. is a publicly held personal genomics and biotechnology company based in Sunnyvale, California.
Website: https://www.23andme.com/
Founded: 2006
CEO / Co-Founder: Anne Wojcicki
Sector: Professional, Scientific, and Technical Services
Industry: Testing Laboratories
